--- title: CROs offering Bioanalysis with Biologics (Other) path: /explore/bioanalysis/biologics-other companies_count: 37 --- # CROs offering Bioanalysis with Biologics (Other) 37 published CROs match Bioanalysis and Biologics (Other). Locations in this set include United States, China, India, United Kingdom, Netherlands, and Australia. Capabilities that show up most often in this set: Biomarker Assays, Regulatory Affairs, Immunogenicity Assays (ADA / NAb), Ligand-Binding Bioanalysis (Large Molecule), and Phase II Clinical Trials. ## Matching companies - [Accutest Research Laboratories](/companies/accutestglobal) - Independent Indian CRO focused on BA/BE studies, Phase II–IV clinical development, and biologics bioanalysis. Operates 262 clinic beds and 21 LC-MS/MS systems across Mumbai and Vadodara. - [Altasciences](/companies/altasciences) - Mid-size early phase CRO/CDMO in Canada and the U.S. offering preclinical safety testing, clinical pharmacology (Phase I–II), bioanalysis, research services, and manufacturing with integrated capabilities. - [Amador Bioscience](/companies/amadorbioscience) - Amador Bioscience provides bioanalysis and biomarker services, including LCMS, immunoassays, flow cytometry, and immunogenicity testing, alongside clinical pharmacology modeling and regulatory affairs support. Its labs are GLP compliant, and its teams work across the US, China, and Europe. - [Aragen Life Sciences](/companies/aragen) - Global CRDMO partner offering integrated discovery-to-commercialization services across small molecules and biologics, with 4000+ scientists and R&D/manufacturing campuses in Asia, North America, and Europe. - [BioAgilytix](/companies/bioagilytix) - Bioanalytical CRO specializing in pharmacokinetics, immunogenicity, biomarkers, and CMC analytics with 30+ years of experience and 1,100+ employees conducting 5M+ tests annually. - [BioDuro-Sundia](/companies/bioduro-sundia) - BioDuro-Sundia is a contract research, development, and manufacturing organization (CRDMO) with 30 years of expertise providing integrated drug discovery, development, and manufacturing services from target identification through IND submission. - [Celerion](/companies/celerion) - Global CRO specializing in early-phase clinical research and bioanalytical sciences with 650+ beds across 30 countries and 50+ years of experience. - [Certara](/companies/certara) - Certara transforms drug development with proprietary biosimulation software, predictive modeling, and AI-driven services spanning discovery through commercialization. Serving 2,400+ biopharmaceutical companies and regulatory agencies across 70 countries, Certara's model-informed drug development (MIDD) platform accelerates clinical and regulatory decision-making. - [Champions Oncology](/companies/championsoncology) - Leading oncology CRO specializing in preclinical and clinical specialty testing, with over 1,400 patient-derived xenograft models, comprehensive multi-omic datasets, and proprietary platforms including flow cytometry, NGS, proteomics, and histopathology services. - [ChemPartner](/companies/chempartner) - Global preclinical CRO with 20+ years of experience supporting drug discovery through IND submission across small molecules and biologics, with 2,000+ scientists and facilities worldwide. - [Chimera Biotec GmbH](/companies/chimera-biotec) - Chimera Biotec offers GLP/GCP ultra-sensitive bioanalysis built on its proprietary Imperacer Immuno-PCR platform. Capabilities cover custom immunoassay development, assay transfer, and ADA/immunogenicity and PK/PD assays down to sub-pg/ml levels. - [Custom Biologics](/companies/custombiologics) - Global bioanalytical CRO offering GLP-compliant assay development, validation, and testing for large-molecule biopharmaceuticals. Supports pre-clinical/CMC and clinical stages, including GMP-lot and market release testing. - [Emery Pharma](/companies/emerypharma) - Full-service CRO delivering analytical, bioanalytical, and microbiology services across small molecules, biologics, gene therapy, and botanical drugs from discovery through clinical development. - [Fog City Bio](/companies/fogcitybio) - Specialized CRO for custom immunoassay development using Simoa, HTRF, AlphaLISA, Luminex, MSD ECL, and other platforms. Direct scientist communication with rapid optimization workflows. - [ICON plc](/companies/iconplc) - ICON is a global clinical research organization providing full-service drug development and clinical trial solutions across early phase through post-marketing, including clinical operations, bioanalytical labs, cardiac safety, medical imaging, and regulatory affairs. - [IQVIA](/companies/iqvia) - IQVIA is a global life sciences and healthcare company providing data, expertise, AI, analytics, and technology solutions to support clinical development and improve patient outcomes. - [Labcorp](/companies/labcorp) - Labcorp is a global life sciences and healthcare company providing diagnostic testing, drug development, nonclinical research, central laboratory services, and real-world data solutions to healthcare providers, health systems, and biopharma companies. - [Medpace](/companies/medpace) - Full-service CRO with 30+ years of organic growth, offering integrated clinical development services across all phases with wholly-owned central labs, bioanalytical lab, imaging core lab, and Phase I unit. - [Noble Life Sciences](/companies/noblelifesci) - Advanced preclinical CRO providing comprehensive drug and device development services including bioanalysis, GLP toxicology, pharmacodynamic modeling, and specialized testing for oncology, infectious disease, gene therapy, and synthetic biology programs. - [NorthEast BioLab](/companies/nebiolab) - Bioanalytical CRO providing PK/PD, immunogenicity (ADA/nAb), cytokine, and biomarker assays across LC-MS, Meso Scale Discovery, ELISA, and ddPCR platforms. Operates GLP/GCLP-compliant facilities and reports DEA and CT approval for Schedule I–IV bioanalysis.